s6y
Company name or ticker
Search
Biomea Fusion, Inc.
4
A2A Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
Filed
Wednesday, April 26, 2023
Period
Apr 20, 2023
Accession number
0001859061-23-000004
Documents
PRIMARY DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header